Law and research could add up to profitable niche drugs
Burkhard Haefner
Additional contact information
Burkhard Haefner: Johnson & Johnson Pharma Research and Development, Turnhoutseweg 30, Box 6423
Nature, 2007, vol. 446, issue 7138, 856-856
Date: 2007
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/446856b Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:446:y:2007:i:7138:d:10.1038_446856b
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/446856b
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().